Global Diabetes Management Platform Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Diabetes Management Platform Market 2024 by Company, Regions, Type and Application, Forecast to 2030

According to our (Global Info Research) latest study, the global Diabetes Management Platform market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Diabetes management platform is a digital tool for diabetics and high risk individuals that allow users to self-manage their treatment and directly connect with specialists. These digital tools improves the Quality of Life (QoL) and reduces the health related costs to users. These platforms helps the patient to track health data, connect to specialist, engage in a community exchange, and allows access to knowledge resources and practical tips about diabetes management. These platforms includes advisory applications for smart insulin pens and smartphone based artificial pancreas system that automatically regulates the insulin delivery, reduces the hypoglycaemic attacks and significantly improves the blood glucose level. These tools equip healthcare professionals with data-driven insights into patient’s habits, areas of risk and opportunities for parameter changes.

According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.

Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

The Global Info Research report includes an overview of the development of the Diabetes Management Platform industry chain, the market status of Hospitals (Web Application, Mobile Application), Specialty Clinics (Web Application, Mobile Application), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Diabetes Management Platform.

Regionally, the report analyzes the Diabetes Management Platform markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Diabetes Management Platform market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Diabetes Management Platform market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Diabetes Management Platform industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Web Application, Mobile Application).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Diabetes Management Platform market.

Regional Analysis: The report involves examining the Diabetes Management Platform market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Diabetes Management Platform market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Diabetes Management Platform:

Company Analysis: Report covers individual Diabetes Management Platform players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Diabetes Management Platform This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Specialty Clinics).

Technology Analysis: Report covers specific technologies relevant to Diabetes Management Platform. It assesses the current state, advancements, and potential future developments in Diabetes Management Platform areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Diabetes Management Platform market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Diabetes Management Platform market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Web Application
Mobile Application
SMS/USSD Application

Market segment by Application
Hospitals
Specialty Clinics
Long-Term Care Centers
Ambulatory Surgical Centers

Market segment by players, this report covers
GLUKOA
TypeZero Technologies
BioTelemetry
CELLNOVO
STARsystem By Sanofi
WellDoc
Tactio Health
Livongo Health

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Diabetes Management Platform product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Diabetes Management Platform, with revenue, gross margin and global market share of Diabetes Management Platform from 2019 to 2024.

Chapter 3, the Diabetes Management Platform competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Diabetes Management Platform market forecast, by regions, type and application, with consumption value, from 2025 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Diabetes Management Platform.

Chapter 13, to describe Diabetes Management Platform research findings and conclusion.